XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.3
CHINA JOINT VENTURE
9 Months Ended
Sep. 30, 2023
Noncontrolling Interest [Abstract]  
CHINA JOINT VENTURE CHINA JOINT VENTURE
In 2019, the Company executed a joint venture agreement with its Chinese supplier (the “China JV”) whereby the Company has a 51% interest. The China JV has been consolidated in these condensed consolidated financial statements. The agreement required the Company to make capital contributions into the newly formed entity of approximately $357,000, of which approximately $203,000 and $154,000, respectively, were contributed during the years ended December 31, 2021 and 2020. In June 2023, the Company executed an amendment to the joint venture agreement to increase the amount of it’s registered capital. The amendment requires the Company to make additional capital contributions to the China JV of $255,000, of which $153,000 has been made as of September 30, 2023. As of the date of these condensed consolidated financial statements, the joint venture has not commenced principal operations.

Changes in the Companys ownership investment in the China JV were as follows:

Three Months Ended September 30,Nine Months Ended
September 30,
(In thousands)2023202220232022
Beginning interest in China JV$142$269$219$317
Contributions $153$$153$
Net loss attributable to Apyx$(48)$(33)$(125)$(81)
Ending interest in China JV$247$236$247$236